⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL179570 | 0.79 | — | — | |
| SCHEMBL23202631 | 0.77 | — | — | |
| SCHEMBL18780480 | 0.77 | — | — | |
| SCHEMBL8941385 | 0.75 | — | — | |
| SCHEMBL15606714 | 0.75 | — | — | |
| SCHEMBL29183039 | 0.75 | FAAH (0.41) | — | |
| SCHEMBL16945372 | 0.75 | — | — | |
| SCHEMBL19770803 | 0.75 | — | — | |
| SCHEMBL3151556 | 0.75 | FAAH (0.41) | — | |
| SCHEMBL12597840 | 0.75 | FAAH (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100292218-A1 | Treatment Of Neurofibromatosis With Radicicol And Its Derivatives | NEXGENIX PHARMACEUTICALS HOLDINGS, INC. | 2010-11-18 | — | — | US | disclosed |